A recent report published by Infinium Global Research on the hyperhidrosis treatment market provides an in-depth analysis of segments and sub-segments in the global as well as regional hyperhidrosis treatment market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional hyperhidrosis treatment market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast, and dollar values of the global hyperhidrosis treatment market. According to the report, the global hyperhidrosis treatment market is projected to grow at a CAGR of 5.0% over the forecast period of 2020-2026. The global market for Hyperhidrosis Treatment was estimated to be near USD 1.5 billion in 2020 and is expected to reach over USD 2 billion by 2026.
The abnormal excessive sweating that is not specifically caused by or related to heat or exercise is known as hyperhidrosis. The sweating experienced is excessive with hyperhidrosis as compared to normal sweating. This can be passed down genetically or can be caused due to stress, unhealthy diet, modern lifestyle, stress, and others. Hyperhidrosis is of two types Primary focal Hyperhidrosis and Secondary generalized Hyperhidrosis. Primary Focal Hyperhidrosis is rare and it affects women and men equally. Secondary Generalized Hyperhidrosis is a more commonly found disease type of hyperhidrosis. This disease can have devastating psychological effects on a person such as social anxiety and embarrassment. Hyperhidrosis can also have emotional effects on people. People suffering from Hyperhidrosis are more prone to skin diseases Hyperhidrosis can be treated through various methods such as Antiperspirants, Iontophoresis, Psychotherapy, Botulinum Toxin A, Surgical Treatment, Sympathectomy, Laser Treatments, and others.
According to the International Hyperhidrosis Society, 5% or 365 million people of the world population suffer from hyperhidrosis and excessive sweating. There has been a constant rise in the prevalence of Hyperhidrosis across the world. This increase in the number of people suffering from hyperhidrosis is leading to increasing in demand for treatment. Due to the rise in internet penetration, increased digitalization the access to information is becoming easier for people. As a result, the awareness regarding Hyperhidrosis treatment methods and medications is also increasing. Promotional campaigns by the companies providing treatment are also aiding in this awareness. Various awareness drives regarding hyperhidrosis by governments, NGOs, organizations, and individuals are helping in increasing awareness. The availability of treatment and medications across the borders due to increased globalization is acting as a growth factor for the market. Thus, the market is majorly driven by all these things. Although there is an increase in awareness, the cost of these treatments and medications is high. This is the only restraint to the market. The emergence of new treatments and medications and increasing investment in the same by the companies is expected to provide new opportunities to the market.
North America region is anticipated to be the highest revenue-generating region geographically. There has always been the prevalence of Hyperhidrosis in the North American region. According to research published in the Archives of Dermatological Research (2016) Journal, there was a 4.8% prevalence of hyperhidrosis affecting nearly 15.3 million people of the total population suffering from Hyperhidrosis in the USA. This region is home to advanced societies and economies. Thus, people here follow an unhealthy diet, consumption of alcohol, sedimentary lifestyle and are highly prone to depression and secondary hyperhidrosis is associated with these things. All these things are or become causes for hyperhidrosis. Europe and Asia-Pacific are expected to be the second and third largest revenue-generating regions. Europe and Asia-Pacific both are also witnessing a surge in the number of people affected by Hyperhidrosis.
The report on the global hyperhidrosis treatment market covers segments such as treatment type, disease type, and end-user. On the basis of treatment type, the sub-markets include botulinum toxin a, laser treatments, surgical treatments, topical treatments, and others. On the basis of disease type, the sub-markets include primary focal hyperhidrosis, and secondary generalized hyperhidrosis. On the basis of end-user, the sub-markets include hospitals, ambulatory surgical centers, and others.
The report provides profiles of the companies in the market such as Brickell Biotech, Inc., Sientra, Inc., Revance Therapeutics, Inc., AbbVie, Inc., Allergan, Inc., Brickell Biotech, Inc., Dermira, Inc, GlaxoSmithKline plc, Ulthera, Inc., and TheraVida, Inc.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the hyperhidrosis treatment market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.